DNA methylation prognostic biomarker for stage I NSCLC

被引：0
|
作者：
机构：
来源：
Nature Reviews Clinical Oncology | 2013年 / 10卷 / 12期
关键词：
D O I：
10.1038/nrclinonc.2013.187
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：666 / 666
相关论文
共 50 条
  • [1] Development of prognostic biomarker in pathologic stage I NSCLC patients: Protein expressions involving in DNA damage response.
    Ryu, J. S.
    Choi, C.
    Yang, S.
    Nam, H.
    Kim, H.
    Lee, M. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [2] Stage I NSCLC: elucidating the prognostic factors
    Pham, DuyKhanh
    Harpole, David H.
    THORAX, 2009, 64 (03) : 185 - 186
  • [3] A Prognostic DNA Methylation Signature for Stage I Non-Small-Cell Lung Cancer
    Sandoval, Juan
    Mendez-Gonzalez, Jesus
    Nadal, Ernest
    Chen, Guoan
    Carmona, F. Javier
    Sayols, Sergi
    Moran, Sebastian
    Heyn, Holger
    Vizoso, Miguel
    Gomez, Antonio
    Sanchez-Cespedes, Montse
    Assenov, Yassen
    Mueller, Fabian
    Bock, Christoph
    Taron, Miquel
    Mora, Josefina
    Muscarella, Lucia A.
    Liloglou, Triantafillos
    Davies, Michael
    Pollan, Marina
    Pajares, Maria J.
    Torre, Wenceslao
    Montuenga, Luis M.
    Brambilla, Elisabeth
    Field, John K.
    Roz, Luca
    Lo Iacono, Marco
    Scagliotti, Giorgio V.
    Rosell, Rafael
    Beer, David G.
    Esteller, Manel
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (32) : 4140 - +
  • [4] A 5-gene DNA methylation signature is a promising prognostic biomarker for early-stage cervical cancer
    Chen, Hongxia
    Li, Hongying
    Wang, Lei
    Li, Yaxiong
    Yang, ChunYan
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2022, 42 (02) : 327 - 332
  • [5] DNA Methylation as a Diagnostic, Prognostic, and Predictive Biomarker in Head and Neck Cancer
    Liouta, Galateia
    Adamaki, Maria
    Tsintarakis, Antonis
    Zoumpourlis, Panagiotis
    Liouta, Anastasia
    Agelaki, Sofia
    Zoumpourlis, Vassilis
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [6] DNA methylation in rectal cancer: A new diagnostic and prognostic biomarker panel
    Exner, R.
    Pulverer, W.
    Wolf, B.
    Bergmann, M.
    Weinhaeusel, A.
    Egger, G.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S399 - S399
  • [7] FOXP family DNA methylation correlates with immune infiltration and prognostic value in NSCLC
    Hu, Dong-Mei
    Zhang, Wen-Di
    Shi, Zhuang-E
    Zhang, Meng-Yu
    Li, Rui
    Wang, Qing-Xiang
    Ji, Xiu-Li
    Qu, Yi-Qing
    FRONTIERS IN GENETICS, 2022, 13
  • [8] An Integrated Prognostic Classifier for Stage I Lung Adenocarcinoma Based on mRNA, microRNA, and DNA Methylation Biomarkers
    Robles, Ana I.
    Arai, Eri
    Mathe, Ewy A.
    Okayama, Hirokazu
    Schetter, Aaron J.
    Brown, Derek
    Petersen, David
    Bowman, Elise D.
    Noro, Rintaro
    Welsh, Judith A.
    Edelman, Daniel C.
    Stevenson, Holly S.
    Wang, Yonghong
    Tsuchiya, Naoto
    Kohno, Takashi
    Skaug, Vidar
    Mollerup, Steen
    Haugen, Aage
    Meltzer, Paul S.
    Yokota, Jun
    Kanai, Yae
    Harris, Curtis C.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (07) : 1037 - 1048
  • [9] Targeted Methylation Analysis of Circulating Cell-Free DNA to Predict Outcomes in Clinical Stage I NSCLC Patients
    Bosse, Y.
    Abbosh, C.
    Abadier, M.
    Das Gupta, A.
    Armero, V. Saavedra
    Gaudreault, N.
    Orain, M.
    Lamaze, F.
    Tom, J.
    Melton, C.
    Hung, T.
    Hodgson, D.
    Joubert, P.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S583 - S583
  • [10] The prognostic significance of circulating angiogenesis biomarkers in stage I NSCLC.
    Borgia, Jeffrey Allen
    Pithadia, Ravi
    Seder, Christopher W.
    Tarhoni, Imad
    Basu, Sanjib
    Fhied, Cristina
    Lie, Wen-rong
    Mistry, Jehangir Sorabji
    Chmielewski, Gary
    Bonomi, Philip
    Liptay, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345